Dr. Flanagan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
813 Shades Creek Pkwy
Ste 205
Birmingham, AL 35209Phone+1 205-578-1799Fax+1 205-578-3158
Education & Training
- SSM Health/Saint Louis University School of MedicineResidency, Dermatology, 2008 - 2011
- Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 2002 - 2005
- University of Alabama Medical CenterResidency, Internal Medicine, 1999 - 2002
- University of Tennessee Health Science Center College of MedicineClass of 1999
Certifications & Licensure
- AL State Medical License 2001 - 2024
- MO State Medical License Active through 2013
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 14 citationsBotulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.Katherine H Flanagan, Rosemary King, Dee Anna Glaser
Journal of Drugs in Dermatology. 2008-03-01 - 17 citationsThe methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in childrenSyed I. Rahman, Elaine C. Siegfried, Katherine H. Flanagan, Eric S. Armbrecht
Journal of the American Academy of Dermatology. 2014-02-01 - 15 citationsAn open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.Katherine H Flanagan, Dee Anna Glaser
Journal of Drugs in Dermatology. 2009-05-01
Press Mentions
- The Secret to Flawless SkinJune 24th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: